DIS vs JNJ: Which Is the Better Buy?
Side-by-side comparison of The Walt Disney Company and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
The Walt Disney Company · Communication Services
$101.31
+66.6% upside to fair value
Grade B
VS
Johnson & Johnson · Healthcare
$230.69
+14.0% upside to fair value
Grade C
High Quality
QuantHub Verdict
DIS has more upside to fair value
(+66.6%).
DIS trades at a lower forward P/E
(14.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DIS |
JNJ |
| Current Price |
$101.31 |
$230.69 |
| Fair Value Estimate |
$168.80 |
$263.05 |
| Upside to Fair Value |
+66.6%
|
+14.0%
|
| Market Cap |
$179.5B |
$555.9B |
| Forward P/E |
14.8x
|
26.8x
|
| EV / EBITDA |
11.4x
|
18.5x
|
| Price / Sales |
1.9x
|
5.8x
|
| Price / FCF |
25.4x
|
28.2x
|
| Revenue Growth YoY |
+5.2%
|
+9.9%
|
| Gross Margin |
37.3%
|
69.1%
|
| Operating Margin |
14.2%
|
26.9%
|
| Return on Equity |
11.3%
|
26.5%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.93%
|
3.54%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
The Walt Disney Company operates as a diversified entertainment giant with strong competitive advantages from its vast intellectual property portfolio, global theme parks, and growing direct-to-consumer streaming platforms. The company demonstrates medium business quality with a durable moat supported by iconic brands and infrastructure, but faces execution risks in streaming profitability and pa…
Johnson & Johnson is a leading healthcare company focused on pharmaceuticals and medical devices following its consumer health spin-off. The business quality is high due to its durable competitive moat, diversified portfolio, and strong management with deep institutional knowledge. Despite a 52.4% decline in earnings in the most recent quarter, revenue grew 9.9% year-over-year in the same period,…
Accumulation Zones
| Metric |
DIS |
JNJ |
| Zone Low |
$126.60 |
$197.29 |
| Zone High |
$143.48 |
$223.59 |
| In Buy Zone? |
Yes
|
No
|